Search Results - "Drize, N I"

Biogenesis of Mitochondria in Multipotent Mesenchymal Stromal Cells in Patients with Acute Leukemia by Sadovskaya, A. V., Petinati, N. A., Sats, N. V., Drize, N. I., Vasil’eva, A. N., Aleshina, O. A., Parovichnikova, E. N.

“…In patients with acute leukemia, not only normal hematopoiesis, but also bone marrow stromal microenvironment is damaged. Multipotent mesenchymal stromal cells…”
Get full text

Dynamics of Changes in the Properties of Multipotent Mesenchymal Stromal Cells in Patients with Acute Leukemia by Sadovskaya, A. V., Petinati, N. A., Kapranov, N. M., Drize, N. I., Vasil’eva, A. N., Aleshina, O. A., Parovichnikova, E. N.

“…In acute leukemia, the stromal microenvironment of the bone marrow that regulates hematopoiesis is modified under the influence of malignant cells…”
Get full text

Differences in Protein Secretion by Multipotent Mesenchymal Stromal Cells Effective and Ineffective in the Prevention of Acute Graft—Versus—Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation by Petinati, N. A., Drize, N. I., Arapidi, G. P., Shender, V. O., Lagar’kova, M. A., Kuz’mina, L. A., Parovichnikova, E. N., Savchenko, V. G.

“…Multipotent mesenchymal stromal cells (MSC) were administered to patients after allogeneic hematopoietic stem cell transplantation to prevent the development…”
Get full text

Multipotent mesenchymal stromal cells application for acute graft versus host disease treatment by Kuzmina, L A, Petinati, N A, Vasilieva, V A, Dovydenko, M V, Drokov, M Y, Davydova, Y O, Kapranov, N M, Sats, N V, Chabaeva, Y A, Kulikov, S M, Gaponova, T V, Drize, N I, Parovichnikova, E N, Savchenko, V G

“…Analysis of the effectiveness of the MSCs aministration as the second- or third-line therapy of acute GVHD (aGVHD) resistant to glucocorticosteroid treatment…”
Get full text

Overexpression in Escherichia coli and purification of human fibroblast growth factor (FGF-2) by Gasparian, M. E, Elistratov, P. A, Drize, N. I, Nifontova, I. N, Dolgikh, D. A, Kirpichnikov, M. P

“…Basic fibroblast growth factor (FGF-2) is a member of a large family of structurally related proteins that affect the growth, differentiation, migration, and…”
Get full text

Investigation of the mesenchymal stem cell compartment by means of a lentiviral barcode library by Bigildeev, A. E., Cornils, K., Aranyossy, T., Sats, N. V., Petinati, N. A., Shipounova, I. N., Surin, V. L., Pshenichnikova, O. S., Riecken, K., Fehse, B., Drize, N. I.

“…The hematopoietic bone marrow microenvironment is formed by proliferation and differentiation of mesenchymal stem cells (MSCs). The MSC compartment has been…”
Get full text

Stable Lentiviral Vector Transfer into Mesenchymal Stem Cells In Vivo by Sats, N. V., Shipunova, I. N., Bigil’diev, A. E., Drize, N. I.

“…Green fluorescent protein (eGFP) gene was transferred into mouse mesenchymal stem cells in vivo using a lentiviral vector. In 2 months after injection of the…”
Get full text

Peculiarities of Gene Transfer into Mesenchymal Stem Cells by Sats, N. V., Shipunova, I. N., Bigil’diev, A. E., Kostyushev, D. S., Drize, N. I.

“…Murine mesenchymal stem cells in long-term bone marrow culture were genetically labeled using lentiviral vector carrying enhanced green fluorescent protein…”
Get full text

Characteristics of stromal cell precursors in patients after allogeneic bone marrow transplantation by Petinati, N A, Shipunova, I N, Bigil'deev, A E, Kuz'mina, L A, Saribekian, R A, Gal'tseva, I V, Misiurin, A V, Parovichnikova, E N, Savchenko, V G, Drize, N I

“…AIM. To study the elements of the mesenchymal stromal cell compartment (multipotent mesenchymal stromal cells (MMSCs)) and their more mature progenies of…”
Get full text

Treatment of acute host-versus-graft reaction in patients after allogeneic hematopoietic cell transplantation with multipotent mesenchymal stromal cells from a bone marrow donor by Petinati, N A, Kuz'mina, L A, Parovichnikova, E N, Liubimova, L S, Gribanova, E O, Shipunova, I N, Drize, N I, Savchenko, V G

“…To evaluate the efficiency of administration of multipotent mesenchymal stromal cells obtained from a bone marrow donor for the treatment of an acute…”
Get full text

Effect of priming of multipotent mesenchymal stromal cells with interferon γ on their immunomodulating properties by Kapranov, N. M., Davydova, Y. O., Galtseva, I. V., Petinati, N. A., Drize, N. I., Kuzmina, L. A., Parovichnikova, E. N., Savchenko, V. G.

“…Multipotent mesenchymal stromal cells (MSCs) are widely used for cell therapy, in particular for prophylaxis and treatment of graft-versus-host disease. Due to…”
Get full text

Bone Marrow Multipotent Mesenchymal Stromal Cells from Patients with Aplastic Anemia Retain Their Ability to Support Hematopoietic Precursors despite Pronounced Changes in Gene Expression by Dorofeeva, A. I., Shipunova, I. N., Drize, N. I., Luchkin, A. V., Abramova, A. V., Fidarova, Z. T., Dvirnyk, V. N., Gal’tseva, I. V., Mikhailova, E. A., Parovichnikova, E. N.

“…The properties of bone marrow-derived multipotent mesenchymal stromal cells (MSC) of patients with aplastic anemia at the onset of the disease are studied…”
Get full text

Analysis of Bone Tissue Condition in Patients with Diffuse Large B-Cell Lymphoma without Bone Marrow Involvement by Fastova, E. A., Magomedova, A. U., Kravchenko, S. K., Petinati, N. A., Sats, N. V., Drize, N. I., Savchenko, V. G.

“…We studied changes in the bone tissue in patients with diffuse large B-cell lymphoma at the onset of the disease ( N =41; before chemotherapy) and 5-16 years…”
Get full text

Changes in Bone Marrow Stromal Progenitor Cells in Patients with Hematoblastosis at the Onset of the Disease by Petinati, N. A., Shipounova, I. N., Fastova, E. A., Magomedova, A. U., Kravchenko, S. K., Chelysheva, E. Yu, Shukhov, O. A., Turkina, A. G., Sats, N. V., Drize, N. I., Parovichnikova, E. N., Savchenko, V. G.

“…Multipotent mesenchymal stromal cells (MSC) are the key regulators of hematopoiesis. We studied changes in MSC characteristics in patients with myeloid…”
Get full text

Analysis of results of acute graft-versus-host disease prophylaxis with donor multipotent mesenchymal stromal cells in patients with hemoblastoses after allogeneic bone marrow transplantation by Shipounova, I. N., Petinati, N. A., Bigildeev, A. E., Zezina, E. A., Drize, N. I., Kuzmina, L. A., Parovichnikova, E. N., Savchenko, V. G.

“…Allogeneic bone marrow transplantation (allo-BMT) is currently the only way to cure many hematoproliferative disorders. However, allo-BMT use is limited by…”
Get full text

Bone Marrow Multipotent Mesenchymal Stromal Cells in Patients with Diffuse Large B-Cell Lymphoma by Fastova, E. A., Magomedova, A. U., Petinati, N. A, Sats, N. V., Kapranov, N. M., Davydova, Yu. O., Drize, N. I., Kravchenko, S. K., Savchenko, V. G.

“…In diffuse large B-cell lymphoma, bone marrow involvement is rarely diagnosed. We compared the properties of bone marrow stromal progenitor cells and the…”
Get full text

Stromal regulation of hemopoietic stem cells in long-term human bone marrow tissue cultures under the effect of parathyroid hormone by Petrova, N V, Svinareva, D A, Nifontova, I N, Momotyuk, K S, Savchenko, V G, Drize, N I

“…We studied the interaction between different categories of hemopoietic precursors with parathyroid hormone-activated stromal microenvironment. Improved…”
Get full text

Analysis of Expression of Genes Involved in Immune Response Modulation in Silent Multipotent Mesenchymal Stromal Cells by Petinati, N. A., Shipunova, I. N., Bigildeyev, A. E., Kuz’mina, L. A., Momotyuk, K. S., Parovichnikova, E. N., Drize, N. I., Savchenko, V. G.

“…The expression of some genes modulating the immune response was studied in multipotent mesenchymal stromal cells (MMSC) from the bone marrow of a healthy…”
Get full text

Characteristics of Leukemia Stem Cells of Murine Myeloproliferative Disease Involving the Liver by Shipounova (Nifontova), I. N., Bigil’diev, A. E., Svinareva, D. A., Drize, N. I.

“…We studied surface phenotype of tumor cells and characterized leukemia stem cells in various cell populations with phenotypes of stem and committed precursor…”
Get full text

Multipotent Mesenchymal Stromal Cells in Patients with Chronic Myeloid Leukemia before Discontinuation of Tyrosine Kinase Inhibitors by Petinati, N. A., Petrova, A. N., Chelysheva, E. Yu, Shukhov, O. A., Bykova, A. V., Nemchenko, I. S., Sats, N. V., Turkina, A. G., Drize, N. I.

“…We analyzed changes in multipotent mesenchymal stromal cells of patients with chronic myeloid leukemia before discontinuation of tyrosine kinase inhibitors…”
Get full text